F. Abel, R. Sjöberg, K. Ejeskär, C. Krona, and T. Martinsson, Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours, Br J Cancer, vol.86, pp.596-604, 2002.

F. Abel, R. Sjöberg, C. Krona, S. Nilsson, and T. Martinsson, Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors, International Journal of Oncology, vol.25, pp.1297-1302, 2004.

R. Acuna-hidalgo, J. A. Veltman, and A. Hoischen, New insights into the generation and role of de novo mutations in health and disease, Genome Biol, vol.17, 2016.

S. H. Aldubayan, M. Giannakis, N. D. Moore, G. C. Han, B. Reardon et al., Inherited DNA-Repair Defects in Colorectal Cancer, The American Journal of Human Genetics, vol.102, pp.401-414, 2018.

A. Alimonti, A. Carracedo, J. G. Clohessy, L. C. Trotman, C. Nardella et al., Subtle variations in Pten dose determine cancer susceptibility, Nature Genetics, vol.42, pp.454-458, 2010.

W. F. Anderson, I. Jatoi, J. Tse, and P. S. Rosenberg, Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer, Journal of Clinical Oncology, vol.28, pp.232-239, 2010.

A. Antczak, W. Klu?niak, D. Woko?orczyk, A. Kashyap, A. Jakubowska et al., A common nonsense mutation of the BLM gene and prostate cancer risk and survival, Gene, vol.532, pp.173-176, 2013.

A. C. Antoniou, S. Casadei, T. Heikkinen, D. Barrowdale, K. Pylkäs et al., Breast-Cancer Risk in Families with Mutations in PALB2, New England Journal of Medicine, vol.371, pp.497-506, 2014.

M. Arena, L. Maurizio, C. Myriam, L. Arnaldo, and . Maria, Mutations of the BIK gene in human peripheral B-cell lymphomas, Genes, Chromosomes and Cancer, vol.38, pp.91-96, 2003.

P. Armitage and R. Doll, The age distribution of cancer and a multi-stage theory of carcinogenesis, British Journal of Cancer, vol.91, 1983.

C. J. Van-asperen, R. M. Brohet, E. J. Meijers-heijboer, N. Hoogerbrugge, S. Verhoef et al., Cancer risks in BRCA2 families: estimates for sites other than breast and ovary, J. Med. Genet, vol.42, pp.711-719, 2005.

J. Bachet, B. Landi, P. Laurent-puig, A. Italiano, A. Le-cesne et al., Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13, Eur. J. Cancer, vol.49, pp.2531-2541, 2013.

J. L. Bakker, E. Thirthagiri, S. E. Mil, . Van, M. A. Adank et al., A Novel Splice Site Mutation in the Noncoding Region of BRCA2: Implications for Fanconi Anemia and Familial Breast Cancer Diagnostics, Human Mutation, vol.35, pp.442-446, 2014.

V. M. Basham, J. M. Lipscombe, J. M. Ward, S. A. Gayther, B. A. Ponder et al., BRCA1 and BRCA2 mutations in a population-based study of male breast cancer, Breast Cancer Research, vol.4, 2001.

D. R. Bentley, S. Balasubramanian, H. P. Swerdlow, G. P. Smith, J. Milton et al., Accurate whole human genome sequencing using reversible terminator chemistry, Nature, vol.456, pp.53-59, 2008.

A. H. Berger, A. G. Knudson, and P. P. Pandolfi, A continuum model for tumour suppression, Nature, vol.476, pp.163-169, 2011.

I. Bieche, A. Khodja, and R. Lidereau, Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma, Oncology Reports, vol.5, pp.267-339, 1998.

G. M. Blue, E. P. Kirk, E. Giannoulatou, S. L. Dunwoodie, J. W. Ho et al., Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Familial Congenital Heart Disease, Journal of the American College of Cardiology, vol.64, pp.2498-2506, 2014.

N. Bogdanova, A. V. Togo, M. Ratajska, W. Klu?niak, Z. Takhirova et al., Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe, Familial Cancer, vol.14, pp.145-149, 2015.

D. Botstein and N. Risch, Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease, JNCI Journal of the National Cancer Institute, vol.33, pp.1310-1316, 1999.

M. Bredel, C. Bredel, D. Juric, G. R. Harsh, H. Vogel et al., High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors, Cancer Res, vol.65, pp.4088-4096, 2005.

L. A. Brinton, T. J. Key, L. N. Kolonel, K. B. Michels, H. D. Sesso et al., Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk, Journal of Clinical Oncology, vol.33, pp.2041-2050, 2015.

R. Brough, J. R. Frankum, S. Costa-cabral, C. J. Lord, and A. Ashworth, Searching for synthetic lethality in cancer, Current Opinion in Genetics & Development, vol.21, pp.34-41, 2011.

E. J. Brown, Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance, Genes & Development, vol.17, pp.615-628, 2003.

E. J. Brown and D. Baltimore, ATR disruption leads to chromosomal fragmentation and early embryonic lethality, Genes Dev, vol.14, pp.397-402, 2000.

H. Brustmann, Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): Expression and correlation in normal, hyperplastic and neoplastic endometrial tissues, Pathology -Research and Practice, vol.203, pp.65-72, 2007.

T. Byrski, R. Dent, P. Blecharz, M. Foszczynska-kloda, J. Gronwald et al., Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1 -positive metastatic breast cancer, Breast Cancer Research, vol.14, 2012.

T. S. Byun, Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint, Genes & Development, vol.19, pp.1040-1052, 2005.

J. Cai, D. Feng, L. Hu, H. Chen, G. Yang et al., FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/?-catenin signalling, British Journal of Cancer, vol.113, p.1720, 2015.

P. J. Campbell, S. Yachida, L. J. Mudie, P. J. Stephens, E. D. Pleasance et al., The patterns and dynamics of genomic instability in metastatic pancreatic cancer, Nature, vol.467, p.1109, 2010.

, Comprehensive molecular characterization of human colon and rectal cancer, Cancer Genome Atlas Network, vol.487, pp.330-337, 2012.

A. M. Casper, P. Nghiem, M. F. Arlt, and T. W. Glover, ATR regulates fragile site stability, Cell, vol.111, pp.779-789, 2002.

A. Castells, Y. Ino, D. N. Louis, V. Ramesh, J. F. Gusella et al., Mapping of a target region of allelic loss to a 0.5-cm interval on chromosome 22q13 in human colorectal cancer, Gastroenterology, vol.117, pp.831-837, 1999.

E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer et al., The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data, Cancer Discov, vol.2, pp.401-404, 2012.

M. Certo, V. Del-gaizo-moore, M. Nishino, G. Wei, S. Korsmeyer et al., Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members, Cancer Cell, vol.9, pp.351-365, 2006.

G. Chakravarty, D. Hadsell, W. Buitrago, J. Settleman, and J. M. Rosen, p190-B RhoGAP regulates mammary ductal morphogenesis, Mol. Endocrinol, vol.17, pp.1054-1065, 2003.

E. H. Cheng, .. A. Wei, M. C. Weiler, S. Flavell, R. A. Mak et al., BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX-and BAK-Mediated Mitochondrial Apoptosis, Molecular Cell, vol.8, pp.705-711, 2001.

D. Chubb, P. Broderick, S. E. Dobbins, M. Frampton, B. Kinnersley et al., Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer, Nature Communications, vol.7, p.11883, 2016.

G. Ciriello, E. Cerami, C. Sander, and N. Schultz, Mutual exclusivity analysis identifies oncogenic network modules, Genome Res, vol.22, pp.398-406, 2012.

D. E. Comings, A General Theory of Carcinogenesis, Proc Natl Acad Sci U S A, vol.70, pp.3324-3328, 1973.

I. Comino-méndez, F. J. Gracia-aznárez, F. Schiavi, I. Landa, L. J. Leandro-garcía et al., Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma, Nature Genetics, vol.43, pp.663-667, 2011.

D. Cortez, S. Guntuku, J. Qin, and S. J. Elledge, ATR and ATRIP: partners in checkpoint signaling, Science, vol.294, pp.1713-1716, 2001.

F. J. Couch, H. Shimelis, C. Hu, S. N. Hart, E. C. Polley et al., Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer, JAMA Oncol, vol.3, pp.1190-1196, 2017.

N. J. Curtin, DNA repair dysregulation from cancer driver to therapeutic target, Nature Reviews Cancer, vol.12, p.801, 2012.

Z. Dai, S. Liu, G. Marcucci, and W. Sadee, 5-Aza-2?-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer), Biochemical and Biophysical Research Communications, vol.351, pp.455-461, 2006.

C. A. Davis, B. C. Hitz, C. A. Sloan, E. T. Chan, J. M. Davidson et al., The Encyclopedia of DNA elements (ENCODE): data portal update, Nucleic Acids Res, vol.46, pp.794-801, 2018.

F. Desmet, D. Hamroun, M. Lalande, G. Collod-béroud, M. Claustres et al., , 2009.

, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, vol.37, pp.67-67

N. Dragojlovic, A. M. Elliott, S. Adam, C. Karnebeek, . Van et al., The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study, Genetics in Medicine, vol.20, p.1013, 2018.

G. Duns, E. Berg, . Van-den, I. Duivenbode, . Van et al.,

, Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma, Cancer Res, vol.70, pp.4287-4291

M. E. Durkin, B. Yuan, X. Zhou, D. B. Zimonjic, D. R. Lowy et al., DLC-1:a Rho GTPase-activating protein and tumour suppressor, Journal of Cellular and Molecular Medicine, vol.11, p.1185, 2007.

F. Durocher, Y. Labrie, P. Soucy, O. Sinilnikova, D. Labuda et al., Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families, BMC Cancer, vol.6, p.230, 2006.

J. W. Edmunds, L. C. Mahadevan, C. , and A. L. , Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation, The EMBO Journal, vol.27, p.406, 2008.

S. M. Edwards, Z. Kote-jarai, J. Meitz, R. Hamoudi, Q. Hope et al., Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene, Am. J. Hum. Genet, vol.72, pp.1-12, 2003.

. Eriscam, Estimation des risques tumoraux dans le syndrome de Lynch -Résultats de l'étude française ERISCAM -Mise à Jour 2010 | hnpcc-lynch, 2010.

Y. Errami, H. Brim, K. Oumouna-benachour, M. Oumouna, A. S. Naura et al., ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability, PLOS ONE, vol.8, p.57871, 2013.

C. R. Espenschied, H. Laduca, S. Li, R. Mcfarland, C. Gau et al., Multigene Panel Testing Provides a New Perspective on Lynch Syndrome, JCO, vol.35, pp.2568-2575, 2017.

G. I. Evan, A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land et al., Induction of apoptosis in fibroblasts by c-myc protein, Cell, vol.69, pp.119-128, 1992.

D. G. Evans, I. Susnerwala, J. Dawson, E. Woodward, E. R. Maher et al., Risk of breast cancer in male BRCA2 carriers, Journal of Medical Genetics, vol.47, pp.710-711, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00557385

H. Farmer, N. Mccabe, C. J. Lord, A. N. Tutt, D. A. Johnson et al., Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, vol.434, p.917, 2005.

E. R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell, vol.61, pp.759-767, 1990.

M. Fedurco, A. Romieu, S. Williams, I. Lawrence, and G. Turcatti, BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies, Nucleic Acids Res, vol.34, pp.22-22, 2006.

T. W. Fitzgerald, S. S. Gerety, W. D. Jones, M. Kogelenberg, . Van et al., Large-scale discovery of novel genetic causes of developmental disorders, Nature, vol.519, p.223, 2015.

P. M. Flatt, K. Polyak, L. J. Tang, C. D. Scatena, M. D. Westfall et al., p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest, Cancer Lett, vol.156, pp.63-72, 2000.

O. Fletcher and R. S. Houlston, Architecture of inherited susceptibility to common cancer, Nature Reviews Cancer, vol.10, p.353, 2010.

P. C. Fong, D. S. Boss, T. A. Yap, A. Tutt, P. Wu et al., Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers, 2009.

A. M. Fontebasso, J. Schwartzentruber, D. Khuong-quang, X. Liu, D. Sturm et al., Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas, Acta Neuropathol, vol.125, pp.659-669, 2013.

W. D. Foulkes, Inherited Susceptibility to Common Cancers, New England Journal of Medicine, vol.359, pp.2143-2153, 2008.

W. D. Foulkes, P. Ghadirian, M. R. Akbari, N. Hamel, S. Giroux et al., Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women, Breast Cancer Research, vol.9, p.83, 2007.

M. Fromer, J. L. Moran, K. Chambert, E. Banks, S. E. Bergen et al., Discovery and Statistical Genotyping of Copy-Number Variation from Whole-Exome Sequencing Depth, The American Journal of Human Genetics, vol.91, pp.597-607, 2012.

P. A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard et al., A census of human cancer genes, Nature Reviews Cancer, vol.4, pp.177-183, 2004.

J. E. Garber and K. Offit, Hereditary Cancer Predisposition Syndromes, JCO, vol.23, pp.276-292, 2005.

T. Garcia-muse and S. J. Boulton, Distinct modes of ATR activation after replication stress and DNA double-strand breaks in Caenorhabditis elegans, The EMBO Journal, vol.24, pp.4345-4355, 2005.

M. Gerlinger, A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder et al., Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing, 2012.

. Ggc-unicancer, UNICANCER -Quels gènes analyser face à un risque de cancer héréditaire du sein et de l'ovaire ?, 2017.

C. Gilissen, J. Y. Hehir-kwa, D. T. Thung, M. Vorst, . Van-de et al., Genome sequencing identifies major causes of severe intellectual disability, Nature, vol.511, pp.344-347, 2014.

T. C. Glenn, Field guide to next-generation DNA sequencers, Mol Ecol Resour, vol.11, pp.759-769, 2011.

K. H. Goss, M. A. Risinger, J. J. Kordich, M. M. Sanz, J. E. Straughen et al., Enhanced Tumor Formation in Mice Heterozygous for Blm Mutation, Science, vol.297, pp.2051-2053, 2002.

R. Govindan, L. Ding, M. Griffith, J. Subramanian, N. D. Dees et al., Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers, Cell, vol.150, pp.1121-1134, 2012.

W. J. Greenleaf and A. Sidow, The future of sequencing: convergence of intelligent design and market Darwinism, Genome Biology, vol.15, p.303, 2014.

C. Greenman, P. Stephens, R. Smith, G. L. Dalgliesh, C. Hunter et al., Patterns of somatic mutation in human cancer genomes, Nature, vol.446, pp.153-158, 2007.

P. V. Gumaste, L. A. Penn, R. M. Cymerman, T. Kirchhoff, D. Polsky et al., Skin cancer risk in BRCA1/2 mutation carriers, Br. J. Dermatol, vol.172, pp.1498-1506, 2015.

E. Half, D. Bercovich, and P. Rozen, Familial adenomatous polyposis, Orphanet Journal of Rare Diseases, vol.4, p.22, 2009.

D. Hanahan and R. A. Weinberg, The Hallmarks of, Cancer. Cell, vol.100, pp.57-70, 2000.

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, pp.646-674, 2011.

J. L. Hayes, A. Tzika, H. Thygesen, S. Berri, H. M. Wood et al., Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation, Genomics, vol.102, pp.174-181, 2013.

J. M. Heather and B. Chain, The sequence of sequencers: The history of sequencing DNA, Genomics, vol.107, pp.1-8, 2016.

B. M. Heckman-stoddard, T. Vargo-gogola, M. P. Herrick, A. P. Visbal, M. T. Lewis et al., P190A RhoGAP is required for mammary gland development, Dev. Biol, vol.360, pp.1-10, 2011.

K. L. Helbig, K. D. Hagman, D. N. Shinde, C. Mroske, Z. Powis et al., , 2016.

L. Hinck and G. B. Silberstein, Key stages in mammary gland development: the mammary end bud as a motile organ, Breast Cancer Res, vol.7, pp.245-251, 2005.

L. A. Hindorff, P. Sethupathy, H. A. Junkins, E. M. Ramos, J. P. Mehta et al., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, PNAS, vol.106, pp.9362-9367, 2009.

S. Horn, A. Figl, P. S. Rachakonda, C. Fischer, A. Sucker et al., TERT Promoter Mutations in Familial and Sporadic Melanoma, vol.339, pp.959-961, 2013.

L. Hou, M. Chen, X. Zhao, J. Li, S. Deng et al., FAT4 functions as a tumor suppressor in triple-negative breast cancer, Tumor Biol, vol.37, pp.16337-16343, 2016.

J. Hur, J. Chesnes, K. R. Coser, R. S. Lee, P. Geck et al., The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.2351-2356, 2004.

J. Hur, D. W. Bell, K. L. Dean, K. R. Coser, P. C. Hilario et al., Regulation of Expression of BIK Proapoptotic Protein in Human Breast Cancer Cells: p53-Dependent Induction of BIK mRNA by Fulvestrant and Proteasomal Degradation of BIK Protein, Cancer Res, vol.66, pp.10153-10161, 2006.

A. Iglesias, K. Anyane-yeboa, J. Wynn, A. Wilson, M. T. Cho et al., The usefulness of whole-exome sequencing in routine clinical practice, Genetics in Medicine, vol.16, p.922, 2014.

. Inca, Epidémiologie des cancers -Les chiffres du cancer en France | Institut National Du Cancer, 2015.

. Inca, Les prédispositions génétiques -Oncogénétique | Institut National Du Cancer, 2015.

. Inca, Oncogénétique en 2016 -Consultations, laboratoires et suivi -Ref : ADONCOG17 | Institut National Du Cancer, 2016.

. Inca, Cancer de l'ovaire et inhibiteur de PARP -Oncogénétique et plateformes de génétique moléculaire, 2017.

I. Iossifov, B. J. O'roak, S. J. Sanders, M. Ronemus, N. Krumm et al., The contribution of de novo coding mutations to autism spectrum disorder, Nature, vol.515, p.216, 2014.

D. R. Iyer and N. Rhind, The Intra-S Checkpoint Responses to DNA Damage, Genes, vol.8, p.74, 2017.

Y. Jiang, S. Shan, L. Chi, G. Zhang, X. Gao et al., Methyl methanesulfonate induces necroptosis in human lung adenoma A549 cells through the PIG-3-reactive oxygen species pathway, Tumor Biol, vol.37, pp.3785-3795, 2016.

S. Jones, R. H. Hruban, M. Kamiyama, M. Borges, X. Zhang et al., Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene, Science, vol.324, pp.217-217, 2009.

R. Jorquera and R. M. Tanguay, Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability, Hum. Mol. Genet, vol.10, pp.1741-1752, 2001.

S. Józwiak, K. Stein, and K. Kotulska, Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex, Future Oncol, vol.8, pp.1515-1523, 2012.

N. Kanu, E. Grönroos, P. Martinez, R. A. Burrell, X. Y. Goh et al., SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair, Oncogene, vol.34, p.5699, 2015.

M. Katoh, Function and cancer genomics of FAT family genes (review), 2012.

K. D. Kernohan, D. A. Dyment, M. Pupavac, Z. Cramer, A. Mcbride et al., Matchmaking facilitates the diagnosis of an autosomalrecessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene, Human Mutation, vol.38, pp.511-516, 2017.

E. Khurana, Y. Fu, D. Chakravarty, F. Demichelis, M. A. Rubin et al., Role of noncoding sequence variants in cancer, Nature Reviews Genetics, vol.17, pp.93-108, 2016.

K. W. Kinzler and B. Vogelstein, Gatekeepers and caretakers, Nature, vol.386, pp.761-763, 1997.

A. De-klein, M. Muijtjens, R. Van-os, Y. Verhoeven, B. Smit et al., Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice, Current Biology, vol.10, pp.479-482, 2000.

A. G. Knudson, Mutation and Cancer: Statistical Study of Retinoblastoma, Proc Natl Acad Sci U S A, vol.68, pp.820-823, 1971.

D. C. Koboldt, K. M. Steinberg, D. E. Larson, R. K. Wilson, and E. R. Mardis, The Next-Generation Sequencing Revolution and Its Impact on, Genomics. Cell, vol.155, pp.27-38, 2013.

H. Kodera, C. Ohba, M. Kato, T. Maeda, K. Araki et al., De novo GABRA1 mutations in Ohtahara and West syndromes, Epilepsia, vol.57, pp.566-573, 2016.

S. Konishi, H. Ishiguro, Y. Shibata, J. Kudo, Y. Terashita et al., Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma, Cancer, vol.95, pp.2473-2478, 2002.

L. A. Korde, J. A. Zujewski, L. Kamin, S. Giordano, S. Domchek et al., Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations, vol.28, pp.2114-2122, 2010.

G. Kovacs, S. Szücs, W. D. Riese, and H. Baumgärtel, Specific chromosome aberration in human renal cell carcinoma, International Journal of Cancer, vol.40, pp.171-178, 1987.

N. Krumm, P. H. Sudmant, A. Ko, B. J. O'roak, M. Malig et al., Copy number variation detection and genotyping from exome sequence data, Genome Res, vol.22, pp.1525-1532, 2012.

K. B. Kuchenbaecker, J. L. Hopper, D. R. Barnes, K. Phillips, T. M. Mooij et al., Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers, JAMA, vol.317, pp.2402-2416, 2017.

T. A. Kunkel, Evolving Views of DNA Replication (In)Fidelity, Cold Spring Harb Symp Quant Biol, vol.74, pp.91-101, 2009.

A. J. Lee, A. P. Cunningham, K. B. Kuchenbaecker, N. Mavaddat, D. F. Easton et al., BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, Br J Cancer, vol.110, pp.535-545, 2014.

J. Lee, Y. Kang, V. Khare, Z. Jin, M. Kang et al., The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage, Oncogene, vol.29, pp.1431-1450, 2010.

F. Lejeune and L. E. Maquat, Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells, Current Opinion in Cell Biology, vol.17, pp.309-315, 2005.

M. Lek, K. J. Karczewski, E. V. Minikel, K. E. Samocha, E. Banks et al., Analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.536, pp.285-291, 2016.

H. Lempiäinen and T. D. Halazonetis, Emerging common themes in regulation of PIKKs and PI3Ks, EMBO J, vol.28, pp.3067-3073, 2009.

A. Letai, Apoptosis and Cancer, Annual Review of Cancer Biology, vol.1, pp.275-294, 2017.

A. Letai, M. C. Bassik, L. D. Walensky, M. D. Sorcinelli, S. Weiler et al., Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics, Cancer Cell, vol.2, pp.183-192, 2002.

K. A. Lewis, S. Mullany, B. Thomas, J. Chien, R. Loewen et al., , 2005.

, Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance, Cancer Res, vol.65, pp.7091-7095

F. Li, G. Mao, D. Tong, J. Huang, L. Gu et al., The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutS?, Cell, vol.153, pp.590-600, 2013.

J. Li, G. Duns, H. Westers, R. Sijmons, A. Berg et al., SETD2: an epigenetic modifier with tumor suppressor functionality, Oncotarget, vol.7, pp.50719-50734, 2016.

J. Li, J. Kluiver, J. Osinga, H. Westers, M. B. Van-werkhoven et al., Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma, Neoplasia, vol.18, pp.339-346, 2016.

A. Lièvre and P. Laurent-puig, RAS/MAPK signaling pathway, 2010.

A. Liu, T. Takakuwa, S. Fujita, M. F. Ham, W. Luo et al., Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma, Lab. Invest, vol.85, pp.436-446, 2005.

A. Liu, T. Takakuwa, S. Fujita, W. Luo, K. Tresnasari et al., ATR alterations in Hodgkin's lymphoma, 2008.

M. Ljungman and D. P. Lane, Transcription -guarding the genome by sensing DNA damage, Nature Reviews Cancer, vol.4, pp.727-737, 2004.

T. F. Logan, Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer, Curr Oncol Rep, vol.15, pp.83-90, 2013.

P. A. Long, B. T. Larsen, J. M. Evans, and T. M. Olson, Exome Sequencing Identifies Pathogenic and Modifier Mutations in a Child With Sporadic Dilated Cardiomyopathy, Journal of the American Heart Association, 2015.

D. Lukasik, E. Wilczek, A. Wasiutynski, and B. Gornicka, Deleted in liver cancer protein family in human malignancies (Review), Oncology Letters, vol.2, p.763, 2011.

D. Ly, D. Forman, J. Ferlay, L. A. Brinton, and M. B. Cook, An international comparison of male and female breast cancer incidence rates, International Journal of Cancer, vol.132, pp.1918-1926, 2013.

J. Majewski, J. Schwartzentruber, E. Lalonde, A. Montpetit, J. et al., What can exome sequencing do for you?, Journal of Medical Genetics, vol.48, pp.580-589, 2011.

J. P. Mathai, M. Germain, R. C. Marcellus, and G. C. Shore, Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53, Oncogene, vol.21, p.2534, 2002.

J. P. Mathai, M. Germain, and G. C. Shore, BH3-only BIK Regulates BAX,BAK-dependent Release of Ca2+ from Endoplasmic Reticulum Stores and Mitochondrial Apoptosis during Stressinduced Cell Death, J. Biol. Chem, vol.280, pp.23829-23836, 2005.

A. Mazouzi, G. Velimezi, and J. I. Loizou, DNA replication stress: Causes, resolution and disease, Experimental Cell Research, vol.329, pp.85-93, 2014.

J. Mccormack, N. J. Welsh, and V. M. Braga, Cycling around cell-cell adhesion with Rho GTPase regulators, J. Cell. Sci, vol.126, pp.379-391, 2013.

R. H. Medema and L. Mac?rek, Checkpoint control and cancer, Oncogene, vol.31, pp.2601-2613, 2012.

H. Meijers-heijboer, A. Van-den-ouweland, J. Klijn, M. Wasielewski, A. De-snoo et al., Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations, Nat. Genet, vol.31, pp.55-59, 2002.

A. Menoyo, H. Alazzouzi, E. Espín, M. Armengol, H. Yamamoto et al., Somatic Mutations in the DNA Damage-Response Genes ATR and CHK1 in Sporadic Stomach Tumors with Microsatellite Instability, Cancer Res, vol.61, pp.7727-7730, 2001.

M. L. Metzker, Sequencing technologies -the next generation, Nature Reviews Genetics, vol.11, pp.31-46, 2010.

H. Mokrani-benhelli, L. Gaillard, P. Biasutto, T. Le-guen, F. Touzot et al., Primary Microcephaly, Impaired DNA Replication, and Genomic Instability Caused by Compound Heterozygous ATR Mutations, Human Mutation, vol.34, pp.374-384, 2013.

U. M. Moll and O. Petrenko, The MDM2-p53 Interaction, Mol Cancer Res, vol.1, pp.1001-1008, 2003.

A. P. Morris, M. Tanya, T. Ferreira, A. V. Segrè, V. Steinthorsdottir et al., Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes, Nature Genetics, vol.44, p.981, 2012.

K. M. Murphy, K. A. Brune, C. Griffin, J. E. Sollenberger, G. M. Petersen et al., Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%, Cancer Res, vol.62, pp.3789-3793, 2002.

S. Nagata, Apoptotic DNA Fragmentation, Experimental Cell Research, vol.256, pp.12-18, 2000.

A. Nakagawara, M. Ohira, H. Kageyama, M. Mihara, S. Furuta et al., Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma, Medical and Pediatric Oncology, vol.35, pp.516-521, 2000.

S. Nambot, J. Thevenon, P. Kuentz, Y. Duffourd, E. Tisserant et al., Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis, Genetics in Medicine, vol.20, pp.645-654, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01635326

N. Navin, J. Kendall, J. Troge, P. Andrews, L. Rodgers et al., Tumour evolution inferred by single-cell sequencing, Nature, vol.472, pp.90-94, 2011.

S. B. Ng, K. J. Buckingham, C. Lee, A. W. Bigham, H. K. Tabor et al., Exome sequencing identifies the cause of a mendelian disorder, Nature Genetics, vol.42, p.30, 2010.

S. Nik-zainal, P. Van-loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman et al., The Life History of 21 Breast Cancers, Cell, vol.149, pp.994-1007, 2012.

I. Nishisho, Y. Nakamura, Y. Miyoshi, Y. Miki, H. Ando et al., Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients, Science, vol.253, pp.665-669, 1991.

C. O'connor, Human Chromosome Translocations and Cancer | Learn Science at Scitable, Nature Education, 2008.

M. O'driscoll and P. A. Jeggo, The role of double-strand break repair -insights from human genetics, Nature Reviews Genetics, vol.7, pp.45-54, 2006.

M. O'driscoll, V. L. Ruiz-perez, C. G. Woods, P. A. Jeggo, and J. A. Goodship, A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome, Nat. Genet, vol.33, pp.497-501, 2003.

T. Ogi, S. Walker, T. Stiff, E. Hobson, S. Limsirichaikul et al., Identification of the First ATRIP-Deficient Patient and Novel Mutations in ATR Define a Clinical Spectrum for ATR-ATRIP Seckel Syndrome, PLOS Genetics, vol.8, 2012.

M. Oh, A. Mcbride, S. Yun, S. Bhattacharjee, M. Slack et al., BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Metaanalysis, J. Natl. Cancer Inst, vol.110, pp.1178-1189, 2018.

L. Ottini, P. Rizzolo, I. Zanna, M. Falchetti, G. Masala et al., BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy, Breast Cancer Research and Treatment, vol.116, pp.577-586, 2009.

C. Palles, J. Cazier, K. M. Howarth, E. Domingo, A. M. Jones et al., Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas, Nature Genetics, vol.45, pp.136-144, 2013.

H. Park, S. Cho, H. Kim, D. Na, J. Y. Han et al.,

, Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer, PNAS, vol.112, pp.12492-12497

I. Y. Park, R. T. Powell, D. N. Tripathi, R. Dere, T. H. Ho et al., Dual Chromatin and Cytoskeletal Remodeling by SETD2, Cell, vol.166, pp.950-962, 2016.

M. T. Parsons, P. J. Whiley, J. Beesley, M. Drost, N. Wind et al., Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity, Molecular Carcinogenesis, vol.54, pp.513-522, 2015.

R. Pearlman, W. L. Frankel, B. Swanson, W. Zhao, A. Yilmaz et al., Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer, JAMA Oncol, vol.3, pp.464-471, 2017.

K. Polyak, Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein, A model for p53-induced apoptosis, Nature, vol.389, pp.300-305, 1997.

N. C. Popescu and S. Goodison, Deleted in Liver Cancer-1 (DLC1): An Emerging Metastasis Suppressor Gene, Mol Diagn Ther, vol.18, pp.293-302, 2014.

S. Porté, E. Valencia, E. A. Yakovtseva, E. Borràs, N. Shafqat et al., Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3, J. Biol. Chem, vol.284, pp.17194-17205, 2009.

Z. Powis, C. R. Espenschied, H. Laduca, K. D. Hagman, T. Paudyal et al., Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent, Cancer Genetics, vol.224, pp.12-20, 2018.

D. Prokofyeva, N. Bogdanova, N. Dubrowinskaja, M. Bermisheva, Z. Takhirova et al., Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations, Breast Cancer Res Treat, vol.137, pp.533-539, 2013.

C. Qi, Y. T. Zhu, L. Hu, and Y. Zhu, Identification of Fat4 as a candidate tumor suppressor gene in breast cancers, Int J Cancer, vol.124, pp.793-798, 2009.

J. Quan, Y. Li, M. Jin, D. Chen, X. Yin et al., Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis, Tumour Biol, vol.39, p.1010428317694572, 2017.

N. Rahman, Realizing the promise of cancer predisposition genes, Nature, vol.505, pp.302-308, 2014.

N. Rahman and R. H. Scott, Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players, Hum Mol Genet, vol.16, pp.60-66, 2007.

N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick et al., PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nature Genetics, vol.39, pp.165-167, 2007.

W. Rauch and . Pfeifer, DNA methylation biomarkers for lung cancer | SpringerLink, 2012.

P. J. Real, C. Sanz, O. Gutierrez, C. Pipaon, A. M. Zubiaga et al., Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells, FEBS Letters, vol.580, pp.5905-5909, 2006.

M. Redza-dutordoir and D. A. Bates, Activation of apoptosis signalling pathways by reactive oxygen species, Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, vol.1863, pp.2977-2992, 2016.

P. P. Reis, S. R. Rogatto, L. P. Kowalski, I. N. Nishimoto, J. C. Montovani et al., Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer, Oncogene, vol.21, p.6480, 2002.

A. Renwick, D. Thompson, S. Seal, P. Kelly, T. Chagtai et al., ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles, Nat. Genet, vol.38, pp.873-875, 2006.

K. Retterer, J. Juusola, M. T. Cho, P. Vitazka, F. Millan et al., Clinical application of whole-exome sequencing across clinical indications, Genet. Med, vol.18, pp.696-704, 2016.

P. Rizzolo, V. Silvestri, S. Tommasi, R. Pinto, K. Danza et al., Male breast cancer: genetics, epigenetics, and ethical aspects, Annals of Oncology, vol.24, pp.75-82, 2013.

J. Roignot, X. Peng, and K. Mostov, Polarity in mammalian epithelial morphogenesis, Cold Spring Harb Perspect Biol, vol.5, 2013.

M. Ronaghi, S. Karamohamed, B. Pettersson, M. Uhlén, and P. Nyrén, Real-Time DNA Sequencing Using Detection of Pyrophosphate Release, Analytical Biochemistry, vol.242, pp.84-89, 1996.

M. Ronaghi, M. Uhlén, and P. Nyrén, A Sequencing Method Based on Real-Time Pyrophosphate, Science, vol.281, pp.363-365, 1998.

J. M. Rothberg, W. Hinz, T. M. Rearick, J. Schultz, W. Mileski et al., An integrated semiconductor device enabling non-optical genome sequencing, Nature, vol.475, pp.348-352, 2011.

J. D. Rowley, Chromosome translocations: dangerous liaisons revisited, Nature Reviews Cancer, vol.1, p.245, 2001.

E. Sahai and C. J. Marshall, RHO-GTPases and cancer, Nature Reviews Cancer, vol.2, p.133, 2002.

K. E. Samocha, E. B. Robinson, S. J. Sanders, C. Stevens, A. Sabo et al., A framework for the interpretation of de novo mutation in human disease, Nature Genetics, vol.46, pp.944-950, 2014.

J. R. Sampson, S. Dolwani, S. Jones, D. Eccles, A. Ellis et al., Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH, The Lancet, vol.362, pp.39-41, 2003.

M. Schwab, C. Praml, and L. C. Amler, Genomic instability in Ip and human malignancies, Genes, Chromosomes and Cancer, vol.16, pp.211-229, 1996.

M. Serrano, A. W. Lin, M. E. Mccurrach, D. Beach, and S. W. Lowe, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell, vol.88, pp.593-602, 1997.

S. P. Shah, R. D. Morin, J. Khattra, L. Prentice, T. Pugh et al., Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution, Nature, vol.461, pp.809-813, 2009.

R. Shaheen, N. Patel, H. Shamseldin, F. Alzahrani, R. Al-yamany et al., Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort, Genetics in Medicine, vol.18, p.686, 2016.

J. Shendure, G. J. Porreca, N. B. Reppas, X. Lin, J. P. Mccutcheon et al., Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome, Science, vol.309, pp.1728-1732, 2005.

M. Shimada, R. Sagae, J. Kobayashi, T. Habu, and K. Komatsu, Inactivation of the Nijmegen Breakage Syndrome Gene Leads to Excess Centrosome Duplication via the ATR/BRCA1 Pathway, Cancer Res, vol.69, pp.1768-1775, 2009.

G. B. Silberstein, Postnatal mammary gland morphogenesis, Microsc. Res. Tech, vol.52, pp.155-162, 2001.

M. J. Smith, J. O'sullivan, S. S. Bhaskar, K. D. Hadfield, G. Poke et al., Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas, Nature Genetics, vol.45, p.295, 2013.

N. Sobreira, F. Schiettecatte, D. Valle, and A. Hamosh, GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene, Hum Mutat, vol.36, pp.928-930, 2015.

A. P. Sokolenko, A. G. Iyevleva, E. V. Preobrazhenskaya, N. V. Mitiushkina, S. N. Abysheva et al., High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia, Int. J. Cancer, vol.130, pp.2867-2873, 2012.

V. Sopik, C. Phelan, C. Cybulski, and S. A. Narod, BRCA1 and BRCA2 mutations and the risk for colorectal cancer, Clin. Genet, vol.87, pp.411-418, 2015.

A. Sottoriva, I. Spiteri, D. Shibata, C. Curtis, and S. Tavaré, Single-Molecule Genomic Data Delineate Patient-Specific Tumor Profiles and Cancer Stem Cell Organization, Cancer Res, vol.73, pp.41-49, 2013.

C. H. Spurrell, Identifying New Genes for Inherited Breast Cancer by Exome Sequencing, 2013.

Z. K. Stadler, P. Thom, M. E. Robson, J. N. Weitzel, N. D. Kauff et al., Genome-Wide Association Studies of Cancer, JCO, vol.28, pp.4255-4267, 2010.

J. L. Stafford, G. Dyson, N. K. Levin, S. Chaudhry, R. Rosati et al., Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability, PLOS ONE, vol.12, 2017.

L. D. Stein, The case for cloud computing in genome informatics, Genome Biology, vol.11, p.207, 2010.

P. J. Stephens, P. S. Tarpey, H. Davies, P. V. Loo, C. Greenman et al., The landscape of cancer genes and mutational processes in breast cancer, Nature, vol.486, pp.400-404, 2012.

H. A. Stessman, M. H. Willemsen, M. Fenckova, O. Penn, A. Hoischen et al., Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders, The American Journal of Human Genetics, vol.98, pp.541-552, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01405534

B. D. Strahl, P. A. Grant, S. D. Briggs, Z. Sun, J. R. Bone et al., Set2 Is a Nucleosomal Histone H3-Selective Methyltransferase That Mediates Transcriptional Repression, Molecular and Cellular Biology, vol.22, pp.1298-1306, 2002.

I. Sturm, C. Stephan, B. Gillissen, R. Siebert, M. Janz et al., Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma, Cell Death Differ, vol.13, pp.619-627, 2005.

E. N. Suspitsin, G. A. Yanus, A. P. Sokolenko, O. S. Yatsuk, O. A. Zaitseva et al., Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele, Med. Oncol, vol.31, p.828, 2014.

L. R. Susswein, M. L. Marshall, R. Nusbaum, K. J. Vogel-postula, S. M. Weissman et al., Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing, Genetics in Medicine, vol.18, pp.823-832, 2016.

Y. C. Tai, S. Domchek, G. Parmigiani, C. , and S. , Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.99, pp.1811-1814, 2007.

A. Tanaka, S. Weinel, N. Nagy, M. O'driscoll, J. E. Lai-cheong et al., Germline mutation in ATR in autosomaldominant oropharyngeal cancer syndrome, Am. J. Hum. Genet, vol.90, pp.511-517, 2012.

J. Y. Tang, J. M. Mackay-wiggan, M. Aszterbaum, R. L. Yauch, J. Lindgren et al., Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome, N. Engl. J. Med, vol.366, pp.2180-2188, 2012.

T. M. Teslovich, K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou et al., Biological, clinical and population relevance of 95 loci for blood lipids, Nature, vol.466, p.707, 2010.

C. Thauvin-robinet, M. Auclair, L. Duplomb, M. Caron-debarle, M. Avila et al., PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy, Am. J. Hum. Genet, vol.93, pp.141-149, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01064045

C. Thauvin-robinet, J. S. Lee, E. Lopez, V. Herranz-pérez, T. Shida et al., The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator of centriole elongation, Nat. Genet, vol.46, pp.905-911, 2014.

C. Thomas and D. Strutt, The roles of the cadherins Fat and Dachsous in planar polarity specification in Drosophila, Developmental Dynamics, vol.241, pp.27-39, 2012.

D. Thompson and D. F. Easton, Cancer Incidence in BRCA1 Mutation Carriers, Journal of the National Cancer Institute, vol.94, 2002.

E. R. Thompson, M. A. Doyle, G. L. Ryland, S. M. Rowley, D. Y. Choong et al., Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles, PLoS Genetics, vol.8, 2012.

E. R. Thompson, S. M. Rowley, N. Li, S. Mcinerny, L. Devereux et al., Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care, Journal of Clinical Oncology, vol.34, pp.1455-1459, 2016.

C. Tomasetti, L. Marchionni, M. A. Nowak, G. Parmigiani, and B. Vogelstein, Only three driver gene mutations are required for the development of lung and colorectal cancers, PNAS, vol.112, pp.118-123, 2015.

I. Tournier, R. Marlin, K. Walton, F. Charbonnier, S. Coutant et al., Germline Mutations of Inhibins in Early-Onset Ovarian Epithelial Tumors, vol.35, pp.294-297, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02375836

W. P. Tsang, S. P. Chau, S. K. Kong, K. P. Fung, and T. T. Kwok, Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis, Life Sciences, vol.73, pp.2047-2058, 2003.

A. Tutt, H. Tovey, M. C. Cheang, S. Kernaghan, L. Kilburn et al., Carboplatin in BRCA1/2 -mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial, Nature Medicine, vol.24, p.628, 2018.

L. Valle, Genetic predisposition to colorectal cancer: Where we stand and future perspectives, World J Gastroenterol, vol.20, pp.9828-9849, 2014.

V. Vassileva, A. Millar, L. Briollais, W. Chapman, and B. Bapat, Genes Involved in DNA Repair Are Mutational Targets in Endometrial Cancers with Microsatellite Instability, Cancer Res, vol.62, pp.4095-4099, 2002.

L. E. Vissers, C. Gilissen, and J. A. Veltman, Genetic studies in intellectual disability and related disorders, Nature Reviews Genetics, vol.17, p.9, 2016.

K. V. Voelkerding, S. A. Dames, and J. D. Durtschi, Next-Generation Sequencing: From Basic Research to Diagnostics, Clinical Chemistry, vol.55, pp.641-658, 2009.

R. M. Voer, . De, M. Hahn, A. R. Mensenkamp, A. Hoischen et al., Deleterious Germline BLM Mutations and the Risk for Early, vol.5, 2015.

B. Vogelstein and K. W. Kinzler, Cancer genes and the pathways they control, Nature Medicine, vol.10, pp.789-799, 2004.

B. Vogelstein, D. Lane, and A. J. Levine, Surfing the p53 network, 2000.

B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz et al., , 2013.

, Cancer Genome Landscapes. Science, vol.339, pp.1546-1558

C. S. Walsh, Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy, Gynecologic Oncology, vol.137, pp.343-350, 2015.

D. M. Walter, O. S. Venancio, E. L. Buza, J. W. Tobias, C. Deshpande et al., Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma, Cancer Res, vol.77, pp.1719-1729, 2017.

D. Wang, X. Qian, M. Rajaram, M. E. Durkin, D. R. Lowy et al., DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers, Oncotarget, vol.7, pp.45144-45157, 2016.

S. Wang, E. A. Konorev, S. Kotamraju, J. Joseph, S. Kalivendi et al., , 2004.

, Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms INTERMEDIACY OF H2O2-AND p53-DEPENDENT PATHWAYS, J. Biol. Chem, vol.279, pp.25535-25543

X. Wei, V. Walia, J. C. Lin, J. K. Teer, T. D. Prickett et al., Exome sequencing identifies GRIN2A as frequently mutated in melanoma, Nature Genetics, vol.43, pp.442-446, 2011.

S. A. Wells, J. E. Gosnell, R. F. Gagel, J. Moley, D. Pfister et al., Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer, J. Clin. Oncol, vol.28, pp.767-772, 2010.

T. L. Wilson, .. Hattangady, N. Lerario, A. M. Williams, C. Koeppe et al., A new POT1 germline mutation expanding the spectrum of POT1-associated cancers, Familial Cancer, vol.16, pp.561-566, 2017.

A. Wodarz and I. Näthke, Cell polarity in development and cancer, Nature Cell Biology, vol.9, p.1016, 2007.

L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjöblom et al., The Genomic Landscapes of Human Breast and Colorectal Cancers, Science, vol.318, pp.1108-1113, 2007.

C. Wyman and R. Kanaar, DNA double-strand break repair: all's well that ends well, Annu. Rev. Genet, vol.40, pp.363-383, 2006.

. Xie, Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes

X. Xu, Y. Hou, X. Yin, L. Bao, A. Tang et al., Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor, Cell, vol.148, pp.886-895, 2012.

S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary et al., Distant metastasis occurs late during the genetic evolution of pancreatic cancer, Nature, vol.467, pp.1114-1117, 2010.

Y. Yang, D. M. Muzny, J. G. Reid, M. N. Bainbridge, A. Willis et al., Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders, New England Journal of Medicine, vol.369, pp.1502-1511, 2013.

C. Yeang, F. Mccormick, and A. Levine, Combinatorial patterns of somatic gene mutations in cancer, The FASEB Journal, vol.22, pp.2605-2622, 2008.

M. B. Yurgelun, M. H. Kulke, C. S. Fuchs, B. A. Allen, H. Uno et al., Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer, JCO, vol.35, pp.1086-1095, 2017.

H. Zhang, P. E. Head, W. Daddacha, S. Park, X. Li et al., ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA, Cell Reports, vol.14, pp.1435-1447, 2016.

J. Zhang, X. Liu, D. C. Scherer, L. Kaer, . Van et al., Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45, PNAS, vol.95, pp.12480-12485, 1998.

Q. Zhang, J. C. Davis, I. T. Lamborn, A. F. Freeman, H. Jing et al., , 2009.

B. S. Zhou and S. J. Elledge, The DNA damage response: putting checkpoints in perspective, Nature, vol.408, pp.433-439, 2000.

X. Zhu, F. He, H. Zeng, S. Ling, A. Chen et al., Identification of functional cooperative mutations of SETD2 in human acute leukemia, Nature Genetics, vol.46, p.287, 2014.